53 studies on MC4R mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
These Stage 1 results from the Daybreak trial provide compelling evidence for the efficacy of Setmelanotide as a targeted therapeutic option for patients with early-onset, severe obesity and hyperphagia driven by MC4R…
This study provides compelling evidence that MC4R activation can positively modulate hippocampal neurogenesis, a process vital for cognitive function and brain plasticity. The ability to enhance both the proliferation…
This groundbreaking structural work provides a molecular blueprint for understanding MC4R activation, which is invaluable for rational drug design. By visualizing the precise binding pockets and conformational changes…
The theoretical assessment of bremelanotide's safety during breastfeeding provides crucial preliminary guidance for healthcare providers and lactating women with HSDD. This initial understanding suggests a potentially…
This research provides crucial insights into the genetic underpinnings of GLP-1 RA response, paving the way for personalized treatment strategies. By identifying individuals most likely to benefit or experience advers…
MC4R agonists represent a highly promising class of drugs for treating obesity, particularly in patients with genetic forms of the disease where other treatments are ineffective. This review underscores the therapeuti…
This study highlights the potential for developing highly selective therapies that target MC4R in POMC neurons to treat obesity and metabolic syndrome without adverse cardiovascular effects. Current MC4R agonists ofte…
This research significantly advances our understanding of the neurobiological circuits that govern gastrointestinal function and energy homeostasis. The identification of brainstem melanocortin signaling as a direct m…
This case study highlights the complex motivations and significant health risks associated with unregulated Melanotan use, particularly in professions where body image is paramount. The sustained use despite adverse e…
This study definitively establishes glutamate as the primary neurotransmitter mediating MC4R function on Sim1 neurons in the complex process of body weight regulation. This fundamental discovery significantly advances…
This case report serves as a stark warning, highlighting a potential severe adverse effect associated with the unregulated use of Melanotan-II. The observed temporal link between MT-II exposure and melanoma diagnosis …
This research reveals a fundamental mechanism by which MC4R agonists can modulate neuronal activity in the amygdala, a brain region critically involved in anxiety, fear responses, and stress-related disorders. The dir…
This research highlights a novel and critical interaction between the melanocortin and endocannabinoid systems within the PVH, a key brain region for energy balance. The finding that CB1 receptor activity in the PVH i…
This research highlights the melanocortin system as a critical mediator of leptin's therapeutic potential in diabetes, even in states of uncontrolled hyperglycemia. Understanding this pathway could pave the way for no…
This research highlights the critical role of the vagus nerve as a key mediator in the brain's melanocortin system for controlling appetite. Understanding this brain-gut axis provides a novel perspective on how centra…
This research highlights a novel and significant interaction between the melanocortin system and the oxytocin system, providing a deeper understanding of the complex neurobiology underlying social bonding. The finding…
This research significantly advances our understanding of the neural mechanisms underlying binge drinking, identifying the lateral hypothalamic melanocortin system as a crucial regulator of alcohol consumption. The fi…
Understanding the temporal dynamics of receptor signaling is crucial for developing more effective and safer therapeutics. This research highlights that MC4R agonists can be tailored not just for their binding affinit…
This study provides crucial insights into how the brain's melanocortin system can directly influence peripheral energy expenditure and heat production, independent of changes in physical activity. The ability to boost…
This study provides compelling evidence that targeting the central melanocortin system offers a powerful and chronic mechanism for body mass reduction. The ability to achieve sustained weight loss without the necessit…
The study definitively demonstrated that GRP78 directly binds to the MC4R, influencing its cell surface expression and signaling efficacy. Co-immunoprecipitation experiments revealed a robust interaction between endog…
This research provides a critical neurobiological link, demonstrating that the melanocortin system directly modulates histaminergic neurons via MC4R in the PFH to influence appetite. This novel pathway offers a deeper…
This research identifies a previously unrecognized brain circuit involving the Mes5 and NTS POMC neurons that plays a crucial role in regulating appetite and body weight. Understanding this pathway could open new aven…
The discovery of functionally selective hMCR agonists represents a significant step forward in melanocortin drug discovery. By selectively modulating specific MCR subtypes or signaling pathways, these novel compounds …
This research is significant because it identifies the nucleus accumbens as a direct target for melanocortin receptor agonists in modulating food-related behaviors. Understanding this localized mechanism could open ne…
This research provides a novel understanding of how the melanocortin system and oxytocin synergistically regulate social reward pathways in the brain. The finding that melanocortin agonism selectively activates the nu…
This comprehensive guide is critically important for advancing MCR research, providing scientists with reliable and well-characterized tools to investigate the complex biology of these receptors. By using recommended …
This review underscores the significant therapeutic potential of alpha-MSH related peptides as a novel class of drugs for treating chronic inflammatory and autoimmune diseases. Their multifaceted mechanism of action, …
This research significantly broadens our understanding of α-MSH's complex anti-inflammatory mechanisms, indicating that its therapeutic potential extends beyond the well-characterized pharmacophore and melanocortin re…
The findings from this study are profoundly significant, as they identify retatrutide as a potentially superior therapeutic agent for MC4R-deficient obesity, a condition notoriously difficult to manage. This MC4R defi…
This research highlights the significant therapeutic potential of melanocortin peptides in addressing unmet medical needs. The development of MTI could offer a novel, preventative approach to skin cancer through induc…
This study is significant because it demonstrates that bremelanotide (PT-141) can effectively improve subjective sexual response in premenopausal women with SAD, addressing a major unmet medical need. By targeting mel…
This review underscores the melanocortin system as a promising, non-vascular target for treating erectile dysfunction, offering a novel mechanism of action distinct from existing therapies. The central action of MC4R …
This comprehensive review underscores the significant therapeutic potential of melanocortin receptor agonists as a novel class of treatments for both male and female sexual dysfunction. Unlike many existing therapies …
This retraction highlights the critical importance of research integrity and transparency in scientific publishing. Unverified or fraudulent data can mislead future research and potentially harm patients if treatments…
This study provides compelling evidence that bremelanotide can be an effective "salvage" therapy for men with erectile dysfunction who do not respond to conventional PDE5 inhibitors like sildenafil. This finding addre…
This case report underscores the significant and potentially life-threatening risks associated with the use of unregulated substances like Melanotan II. It highlights that severe adverse events, such as rhabdomyolysis…
This review underscores the significant therapeutic potential of melanocortin receptor agonists as a novel class of drugs for treating a wide range of sexual dysfunctions. By targeting central neural pathways, these c…
The approval of bremelanotide represents a pivotal advancement in addressing a significant unmet medical need for women experiencing HSDD. Its unique profile as a self-administered, on-demand subcutaneous therapy offe…
The development of reliable and valid patient-reported outcome measures is paramount for accurate diagnosis, effective treatment monitoring, and robust clinical research in conditions like HSDD. This study provides st…
This study provides invaluable real-world evidence regarding the positive patient experience and perceived effectiveness of Bremelanotide for HSDD in premenopausal women. The high rates of satisfaction and tolerabilit…
This study provides crucial evidence that bremelanotide offers a consistently effective treatment option for a broad range of women suffering from HSDD, regardless of their age, menopausal status, or other key demogra…
This review consolidates extensive research, providing a clear roadmap for future drug development targeting the melanocortin system. The identification of potent and selective ligands for MC3R and MC4R offers novel a…
This review profoundly underscores the immense and expanding potential of the central melanocortin system as a drug target for a wide array of metabolic and behavioral disorders. The established safety profile and cli…
This study highlights a critical gender bias in the management of sexual dysfunction within primary care, indicating that women may be systematically underserved. The findings underscore the urgent need for increased …
This research provides crucial insights into the neurobiological underpinnings of bremelanotide's action, specifically highlighting its impact on dopaminergic pathways in a relevant animal model. Understanding these m…